Original Research

Published on 28 Mar 2023

Stylopine: A potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy

in Pharmacology of Anti-Cancer Drugs

Naveen Kumar Velayutham
Tamilanban Thamaraikani
Shadma Wahab
Mohammad Khalid
Gobinath Ramachawolran
Shahabe Saquib Abullais
Ling Shing Wong
Mahendran Sekar
Siew Hua Gan
Angel Jemima Ebenezer

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1150270

3,240 views
1 citation

Original Research

Published on 27 Mar 2023

Polyherbal formulation conjugated to gold nanoparticles induced ferroptosis in drug-resistant breast cancer stem cells through ferritin degradation

in Pharmacology of Anti-Cancer Drugs

Prasanthi Chittineedi
Arifullah Mohammed
Mohammad Khairul Azhar Abdul Razab
Norazlina Mat Nawi
Santhi Latha Pandrangi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1134758

3,564 views
7 citations

Original Research

Published on 27 Mar 2023

Small molecules targeting Pin1 as potent anticancer drugs

in Pharmacology of Anti-Cancer Drugs

Jing Zhang
Wenwen Zhou
Yunyu Chen
Yanchang Wang
Zongru Guo
Wenhui Hu
Yan Li
Xiaomin Han
Shuyi Si

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1073037

3,719 views
11 citations

Original Research

Published on 24 Mar 2023

URB2 as an important marker for glioma prognosis and immunotherapy

in Pharmacology of Anti-Cancer Drugs

Chaoyou Fang
Zeyu Zhang
Yongquan Han
Houshi Xu
Zhengyang Zhu
Yichao Du
Pinpin Hou
Ling Yuan
Anwen Shao
Anke Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1113182

3,506 views
1 citation

Review

Published on 24 Mar 2023

Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer

in Pharmacology of Anti-Cancer Drugs

Xin Zhang
Xuemei Wang
Lijian Hou
Zheng Xu
Yu’e Liu
Xueju Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1130937

4,465 views
11 citations

Review

Published on 24 Mar 2023

Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Xu Huang
Xiao-Yu Li
Wu-Lin Shan
Yao Chen
Qi Zhu
Bai-Rong Xia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1131342

5,941 views
10 citations

Brief Research Report

Published on 23 Mar 2023

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study

in Pharmacology of Anti-Cancer Drugs

A. Iurlo
D. Cattaneo
D. Consonni
F. Castagnetti
M. C. Miggiano
G. Binotto
M. Bonifacio
G. Rege-Cambrin
M. Tiribelli
F. Lunghi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1154377

2,449 views
12 citations

Original Research

Published on 23 Mar 2023

Design, synthesis and anticancer activity studies of 3-(coumarin-3-yl)-acrolein derivatives: Evidenced by integrating network pharmacology and vitro assay

in Pharmacology of Anti-Cancer Drugs

Lexian Chen
Qianqian Lv
Jianghong Cai
Jiajie Liang
Ziyan Liang
Jiahui Lin
Ying Xiao
Ruiyao Chen
Zhiling Zhang
Yue Hong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1141121

2,934 views
6 citations

Review

Published on 23 Mar 2023

Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management—Targeting cancer stem cells in the framework of predictive, preventive, personalized medicine

in Pharmacology of Anti-Cancer Drugs

Lenka Koklesova
Jana Jakubikova
Dana Cholujova
Marek Samec
Alena Mazurakova
Miroslava Šudomová
Martin Pec
Sherif T. S. Hassan
Kamil Biringer
Dietrich Büsselberg

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1121950

5,536 views
11 citations

Review

Published on 23 Mar 2023

An updated overview of anticancer effects of alternariol and its derivatives: underlying molecular mechanisms

in Pharmacology of Anti-Cancer Drugs

Muhammad Torequl Islam
Miquel Martorell
Carlos González-Contreras
Marcelo Villagran
Lorena Mardones
Bekzat Tynybekov
Anca Oana Docea
Ahmad Faizal Abdull Razis
Babagana Modu
Daniela Calina

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1099380

3,463 views
15 citations

Systematic Review

Published on 22 Mar 2023

Hematologic side effects of immune checkpoint inhibitor with or without chemotherapy in patients with advanced and metastatic gastrointestinal cancer: A systematic review and network meta-analysis of phase 3 trials

in Pharmacology of Anti-Cancer Drugs

Jingyi Hou
Ruiyang Xie
Zhuo Zhang
Qianxin Liu
Qian Xiang
Yimin Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1163971

3,373 views
3 citations

Original Research

Published on 22 Mar 2023

Global trends in the health economics field of PD-1/PD-L1 inhibitors: A bibliometric and visualized study

in Pharmacology of Anti-Cancer Drugs

Sicen Lai
Licong Xu
Liang Zhang
Lanyuan Peng
Yixin Li
Yuancheng Liu
Nianzhou Yu
Wangqing Chen
Kai Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1141075

3,743 views
1 citation

Review

Published on 22 Mar 2023

Modulation of redox homeostasis: A strategy to overcome cancer drug resistance

in Pharmacology of Anti-Cancer Drugs

Yang Li
Xiaoyue Zhang
Zhihan Wang
Bowen Li
Huili Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1156538

3,963 views
20 citations

Original Research

Published on 22 Mar 2023

HZ-A-018, a novel inhibitor of Bruton tyrosine kinase, exerts anti-cancer activity and sensitizes 5-FU in gastric cancer cells

in Pharmacology of Anti-Cancer Drugs

Danjing Liu
Wei Xu
Bin Lin
Cong Ji
Minmin Shen
Shuying Shen
Junjie Ma
Xinglu Zhou
Youyou Yan
Bo Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1142127

2,046 views
2 citations

Original Research

Published on 21 Mar 2023

A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo

in Pharmacology of Anti-Cancer Drugs

Shreyas S. Kuduvalli
Precilla S. Daisy
Anandraj Vaithy
Mugilarasi Purushothaman
Arumugam Ramachandran Muralidharan
Kumar B. Agiesh
Markus Mezger
Justin S. Antony
Madhu Subramani
Biswajit Dubashi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1096614

4,685 views
7 citations

Original Research

Published on 21 Mar 2023

Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study

in Pharmacology of Anti-Cancer Drugs

Qiongwen Zhang
Ping He
Tinglun Tian
Xi Yan
Juan Huang
Zhang Zhang
Hong Zheng
Xiaorong Zhong
Ting Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1100556

3,664 views
7 citations

Navigation group

Articles

Stylopine: A potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy

Polyherbal formulation conjugated to gold nanoparticles induced ferroptosis in drug-resistant breast cancer stem cells through ferritin degradation

Small molecules targeting Pin1 as potent anticancer drugs

URB2 as an important marker for glioma prognosis and immunotherapy

Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer

Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study

Design, synthesis and anticancer activity studies of 3-(coumarin-3-yl)-acrolein derivatives: Evidenced by integrating network pharmacology and vitro assay

Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management—Targeting cancer stem cells in the framework of predictive, preventive, personalized medicine

An updated overview of anticancer effects of alternariol and its derivatives: underlying molecular mechanisms

Hematologic side effects of immune checkpoint inhibitor with or without chemotherapy in patients with advanced and metastatic gastrointestinal cancer: A systematic review and network meta-analysis of phase 3 trials

Global trends in the health economics field of PD-1/PD-L1 inhibitors: A bibliometric and visualized study

Modulation of redox homeostasis: A strategy to overcome cancer drug resistance

HZ-A-018, a novel inhibitor of Bruton tyrosine kinase, exerts anti-cancer activity and sensitizes 5-FU in gastric cancer cells

A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo

Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study